BDBM323233 N-[2-(3-butoxy-3-o-tolylazetidin-1-yl)-1-(4-methoxybenzyl)-2-oxoethyl]-3-(1H-imidazol-4-yl)hexylamide::US9630949, 62

SMILES CCCCOC1(CN(C1)C(=O)C(Cc1ccc(OC)cc1)[N-]CCC(CCC)c1c[nH]cn1)c1ccccc1C

InChI Key

Data  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 323233   

TargetMelanocortin receptor 4(Homo sapiens (Human))
Galderma Research & Development

US Patent
LigandPNGBDBM323233(N-[2-(3-butoxy-3-o-tolylazetidin-1-yl)-1-(4-methox...)
Affinity DataEC50:  500nMAssay Description:In the presence of an activator (agonist), the melanocortin receptor will activate the cAMP pathway which, via the CRE-Luc vector, will result in the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMelanocyte-stimulating hormone receptor(Homo sapiens (Human))
Galderma Research & Development

US Patent
LigandPNGBDBM323233(N-[2-(3-butoxy-3-o-tolylazetidin-1-yl)-1-(4-methox...)
Affinity DataEC50:  4.00E+3nMAssay Description:In the presence of an activator (agonist), the melanocortin receptor will activate the cAMP pathway which, via the CRE-Luc vector, will result in the...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent